Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data-Reference-Cited by-同舟云学术

Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data

Published:2012-02-16 Issue:5 Volume:40 Page:1007-1017
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Jones Hannah M.,Barton Hugh A.,Lai Yurong,Bi Yi-an,Kimoto Emi,Kempshall Sarah,Tate Sonya C.,El-Kattan Ayman,Houston J. Brian,Galetin Aleksandra,Fenner Katherine S.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference40 articles.

1. Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

2. Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase

3. Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport

4. Bi Y Kimoto E Sevidal S Jones HM Barton HA Kempshall S Whalen KM Zhang H Ji C Fenner KS . (2012) In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation. Drug Metab Dispos doi: 10.1124/dmd.111.043489 .

5. Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy;Bischoff;Cancer Chemother Rep,1975

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug transporters in drug disposition – highlights from the year 2023;Drug Metabolism Reviews;2024-09-11

2. Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors;Clinical Pharmacokinetics;2024-08

3. Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins;CPT: Pharmacometrics & Systems Pharmacology;2024-04-04

4. In silico modeling and simulation of organ‐on‐a‐chip systems to support data analysis and a priori experimental design;CPT: Pharmacometrics & Systems Pharmacology;2024-02-14

5. Building a Predictive PBPK Model for Human OATP Substrates: a Strategic Framework for Early Evaluation of Clinical Pharmacokinetic Variations Using Pitavastatin as an Example;The AAPS Journal;2024-01-05